Dinah Zur
Ophthalmology — Tel Aviv Sourasky Medical Center, Israel
Dinah Zur
LeadR Profile
Ophthalmology
Subspecialties: Genetics - Neurology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2012 - 2026
Number : 155
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Chorioretinal Scars in Congenital Cytomegalovirus Infection Following Prenatal Valacyclovir Therapy. pregnancy, valacyclovir, cicatrix, cytomegalovirus infections, cytomegalovirus, therapeutics, retinaldehyde, communicable diseases, infections, child, infant | Pediatr Infect Dis J | 2026 | 0 |
| Biomarker-Guided Management in Vitreoretinal Diseases: Integrating Imaging, Pharmacotherapy, and Surgical Decision-Making-A Narrative Review. decision making, drug therapy, biomarkers, tomography, optical coherence, therapeutics, retinal diseases, retinaldehyde | Retina | 2026 | 0 |
| The AP5B1 p.(Leu785Pro) variant is a frequent cause of late-onset macular dystrophy with variable extraocular manifestations. macular degeneration, retina, hearing loss, retinaldehyde | HGG Adv | 2026 | 0 |
| Missense variants in KATNA1 alter microtubule dynamics and underlie dominant macular dystrophy. macular degeneration, genes, cilia, photoreceptor cells, katanin, retinaldehyde, microtubules | Res Sq | 2026 | 0 |
| Machine Learning to Predict Outcomes of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration. eye, injections, macular degeneration, vascular endothelial growth factor a, machine learning, therapeutics, learning, retinaldehyde | Ophthalmol Sci | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map